Common and rare variant associations with clonal haematopoiesis phenotypes

MD Kessler, A Damask, S O'Keeffe, N Banerjee, D Li… - Nature, 2022 - nature.com
Clonal haematopoiesis involves the expansion of certain blood cell lineages and has been
associated with ageing and adverse health outcomes,,,–. Here we use exome sequence …

[HTML][HTML] Clonal dynamics of haematopoiesis across the human lifespan

E Mitchell, M Spencer Chapman, N Williams… - Nature, 2022 - nature.com
Age-related change in human haematopoiesis causes reduced regenerative capacity,
cytopenias, immune dysfunction and increased risk of blood cancer,–, but the reason for …

Genetics and epidemiology of mutational barcode-defined clonal hematopoiesis

SN Stacey, F Zink, GH Halldorsson, L Stefansdottir… - Nature Genetics, 2023 - nature.com
Clonal hematopoiesis (CH) arises when a substantial proportion of mature blood cells is
derived from a single hematopoietic stem cell lineage. Using whole-genome sequencing of …

A practical approach to curate clonal hematopoiesis of indeterminate potential in human genetic data sets

C Vlasschaert, T Mack, JB Heimlich… - Blood, The Journal …, 2023 - ashpublications.org
Clonal hematopoiesis of indeterminate potential (CHIP) is a common form of age-related
somatic mosaicism that is associated with significant morbidity and mortality. CHIP mutations …

Minimal residual disease as a target for liquid biopsy in patients with solid tumours

K Pantel, C Alix-Panabières - Nature Reviews Clinical Oncology, 2024 - nature.com
Metastasis is the leading cause of cancer-related death in patients with solid tumours.
Current imaging technologies are not sufficiently sensitive to detect minimal residual …

Distinct landscape and clinical implications of therapy-related clonal hematopoiesis

K Takahashi, D Nakada, M Goodell - The Journal of Clinical Investigation, 2024 - jci.org
Therapy-related clonal hematopoiesis (t-CH) is defined as clonal hematopoiesis detected in
individuals previously treated with chemotherapy and/or radiation therapy. With the …

Tracking the evolution of therapy-related myeloid neoplasms using chemotherapy signatures

B Diamond, B Ziccheddu, K Maclachlan… - Blood, The Journal …, 2023 - ashpublications.org
Patients treated with cytotoxic therapies, including autologous stem cell transplantation, are
at risk for develo** therapy-related myeloid neoplasms (tMN). Preleukemic clones (ie …

Dynamics of age-versus therapy-related clonal hematopoiesis in long-term survivors of pediatric cancer

K Hagiwara, S Natarajan, Z Wang, H Zubair, HL Mulder… - Cancer discovery, 2023 - AACR
We present the first comprehensive investigation of clonal hematopoiesis (CH) in 2,860 long-
term survivors of pediatric cancer with a median follow-up time of 23.5 years. Deep …

DNMT3A-coordinated splicing governs the stem state switch towards differentiation in embryonic and haematopoietic stem cells

R Ramabadran, JH Wang, JM Reyes, AG Guzman… - Nature cell …, 2023 - nature.com
Upon stimulation by extrinsic stimuli, stem cells initiate a programme that enables
differentiation or self-renewal. Disruption of the stem state exit has catastrophic …

Clonal hematopoiesis in clinical and experimental heart failure with preserved ejection fraction

JD Cochran, Y Yura, MC Thel, H Doviak, AH Polizio… - Circulation, 2023 - Am Heart Assoc
BACKGROUND: Clonal hematopoiesis (CH), which results from an array of nonmalignant
driver gene mutations, can lead to altered immune cell function and chronic disease, and …